She’d acquired HIV as a college student in the 1980s, she told the audience at an infectious disease conference in San ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Citigroup said it’s “very bullish” on Gilead’s HIV franchise, arguing it’s the drugmaker’s biggest value driver as the company’s new ...

US funding cuts will lead to an additional 2,000 new HIV infections each day and over six million further deaths over the ...

This makes Lenacapavir significantly more ... Sub-Saharan Africa Leads Global HIV Decline Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ...

Winnie Byanyima, head of UNAIDS, criticized the impact of reduced U.S. funding in combatting HIV. She proposed a deal to U.S.

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is ...